YungShin Global Holding Corporation (3705.TW)
TWD 65.0
(-1.07%)
TWD 65.0
(-1.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.59 Billion TWD | -13.3% |
| 2022 | 4.14 Billion TWD | -20.52% |
| 2021 | 5.22 Billion TWD | -13.49% |
| 2020 | 6.03 Billion TWD | 1.6% |
| 2019 | 5.94 Billion TWD | 6.73% |
| 2018 | 5.56 Billion TWD | 11.42% |
| 2017 | 4.99 Billion TWD | 19.67% |
| 2016 | 4.17 Billion TWD | 34.42% |
| 2015 | 3.1 Billion TWD | 11.07% |
| 2014 | 2.79 Billion TWD | 8.12% |
| 2013 | 2.58 Billion TWD | 43.96% |
| 2012 | 1.79 Billion TWD | 12.4% |
| 2011 | 1.59 Billion TWD | 19.81% |
| 2010 | 1.33 Billion TWD | 5.66% |
| 2009 | 1.26 Billion TWD | 14.03% |
| 2008 | 1.1 Billion TWD | 0.0% |
| 2006 | 768.02 Million TWD | -5.74% |
| 2005 | 814.77 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.25 Billion TWD | 8.83% |
| 2024 Q1 | 3.9 Billion TWD | 8.64% |
| 2023 Q2 | 4.16 Billion TWD | -0.14% |
| 2023 Q3 | 3.73 Billion TWD | -10.29% |
| 2023 Q1 | 4.16 Billion TWD | 0.47% |
| 2023 Q4 | 3.59 Billion TWD | -3.68% |
| 2023 FY | 3.59 Billion TWD | -13.3% |
| 2022 Q1 | 5.09 Billion TWD | -2.43% |
| 2022 Q4 | 4.14 Billion TWD | -11.67% |
| 2022 Q3 | 4.69 Billion TWD | -12.77% |
| 2022 Q2 | 5.38 Billion TWD | 5.71% |
| 2022 FY | 4.14 Billion TWD | -20.52% |
| 2021 FY | 5.22 Billion TWD | -13.49% |
| 2021 Q4 | 5.22 Billion TWD | -3.77% |
| 2021 Q3 | 5.42 Billion TWD | 4.47% |
| 2021 Q2 | 5.19 Billion TWD | 3.01% |
| 2021 Q1 | 5.04 Billion TWD | -16.46% |
| 2020 Q1 | 5.64 Billion TWD | -4.98% |
| 2020 FY | 6.03 Billion TWD | 1.6% |
| 2020 Q2 | 6.1 Billion TWD | 8.22% |
| 2020 Q3 | 5.95 Billion TWD | -2.55% |
| 2020 Q4 | 6.03 Billion TWD | 1.38% |
| 2019 FY | 5.94 Billion TWD | 6.73% |
| 2019 Q2 | 6.18 Billion TWD | 12.05% |
| 2019 Q3 | 6.09 Billion TWD | -1.44% |
| 2019 Q4 | 5.94 Billion TWD | -2.53% |
| 2019 Q1 | 5.51 Billion TWD | -0.85% |
| 2018 Q2 | 5.64 Billion TWD | 12.71% |
| 2018 FY | 5.56 Billion TWD | 11.42% |
| 2018 Q3 | 5.57 Billion TWD | -1.35% |
| 2018 Q4 | 5.56 Billion TWD | -0.1% |
| 2018 Q1 | 5.01 Billion TWD | 0.32% |
| 2017 Q3 | 4.88 Billion TWD | -0.75% |
| 2017 Q2 | 4.92 Billion TWD | 14.56% |
| 2017 Q1 | 4.29 Billion TWD | 2.98% |
| 2017 FY | 4.99 Billion TWD | 19.67% |
| 2017 Q4 | 4.99 Billion TWD | 2.22% |
| 2016 FY | 4.17 Billion TWD | 34.42% |
| 2016 Q2 | 4.56 Billion TWD | 48.94% |
| 2016 Q4 | 4.17 Billion TWD | 2.83% |
| 2016 Q1 | 3.06 Billion TWD | -1.34% |
| 2016 Q3 | 4.05 Billion TWD | -11.04% |
| 2015 Q3 | 3.03 Billion TWD | -15.62% |
| 2015 FY | 3.1 Billion TWD | 11.07% |
| 2015 Q4 | 3.1 Billion TWD | 2.31% |
| 2015 Q2 | 3.59 Billion TWD | 23.93% |
| 2015 Q1 | 2.9 Billion TWD | 3.81% |
| 2014 Q3 | 2.56 Billion TWD | -17.26% |
| 2014 Q2 | 3.09 Billion TWD | 19.51% |
| 2014 Q1 | 2.59 Billion TWD | 0.24% |
| 2014 FY | 2.79 Billion TWD | 8.12% |
| 2014 Q4 | 2.79 Billion TWD | 9.08% |
| 2013 Q1 | 1.87 Billion TWD | 4.11% |
| 2013 Q2 | 2.48 Billion TWD | 33.1% |
| 2013 Q4 | 2.58 Billion TWD | 9.62% |
| 2013 Q3 | 2.35 Billion TWD | -5.22% |
| 2013 FY | 2.58 Billion TWD | 43.96% |
| 2012 Q2 | 2.21 Billion TWD | 50.58% |
| 2012 Q3 | 1.72 Billion TWD | -21.98% |
| 2012 Q4 | 1.79 Billion TWD | 3.85% |
| 2012 FY | 1.79 Billion TWD | 12.4% |
| 2012 Q1 | 1.47 Billion TWD | -7.87% |
| 2011 Q3 | 1.51 Billion TWD | -25.99% |
| 2011 FY | 1.59 Billion TWD | 19.81% |
| 2011 Q1 | 23.9 Million TWD | -98.21% |
| 2011 Q2 | 2.04 Billion TWD | 8457.2% |
| 2011 Q4 | 1.59 Billion TWD | 5.57% |
| 2010 FY | 1.33 Billion TWD | 5.66% |
| 2010 Q4 | 1.33 Billion TWD | 0.0% |
| 2009 FY | 1.26 Billion TWD | 14.03% |
| 2008 FY | 1.1 Billion TWD | 0.0% |
| 2006 FY | 768.02 Million TWD | -5.74% |
| 2005 FY | 814.77 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Grape King Bio Ltd | 3.88 Billion TWD | 7.327% |
| Standard Chem & Pharm CO., LTD. | 3.05 Billion TWD | -17.896% |
| Maywufa Company Ltd. | 794.91 Million TWD | -352.56% |
| ScinoPharm Taiwan, Ltd. | 1.35 Billion TWD | -165.074% |
| Lotus Pharmaceutical Co., Ltd. | 15.65 Billion TWD | 77.025% |
| LIWANLI Innovation Co., Ltd. | 50.66 Million TWD | -7001.206% |
| PhytoHealth Corporation | 79.84 Million TWD | -4405.343% |
| SCI Pharmtech, Inc. | 1.59 Billion TWD | -126.144% |
| Formosa Laboratories, Inc. | 5.42 Billion TWD | 33.699% |
| PharmaEssentia Corporation | 3.32 Billion TWD | -8.319% |
| Bora Pharmaceuticals Co., LTD. | 13.28 Billion TWD | 72.923% |